Literature DB >> 11561705

Lymphatic filariasis in children: adenopathy and its evolution in two young girls.

G Dreyer1, J Figueredo-Silva, K Carvalho, F Amaral, E A Ottesen.   

Abstract

Lymphatic filariasis is a widespread infectious disease of children in endemic areas, but little is known about the early lymphatic damage in children and its evolution, either with or without treatment. Two girls (ages 6 and 12 years) from a Wuchereria bancrofti endemic region of Brazil presented with chronic inguinal adenopathy. Neither had microfilaremia. By ultrasound both were shown to have living adult worms in their enlarged inguinal nodes and had occult local lymphatic damage (lymphangiectasis). One girl spontaneously developed acute adenitis in the affected node prior to any intervention; this adenitis resolved within 10 days and was associated with the progressive disappearance over 45-90 days of all local abnormalities detectable by ultrasound. In the other child, after treatment with a single dose of diethylcarbamazine (DEC), the same clinical picture of transient adenitis and resolving abnormalities (detectable by ultrasound) occurred. These findings demonstrated filariasis as the cause of adenopathy in children, and also both spontaneous and treatment-induced worm-death, with subsequent reversal of lymphatic abnormalities.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11561705     DOI: 10.4269/ajtmh.2001.65.204

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  5 in total

1.  Economic Costs and Benefits of Community-Based Lymphedema-Management Programs for Lymphatic Filariasis in India.

Authors:  Larry Sawers; Eileen Stillwaggon
Journal:  Am J Trop Med Hyg       Date:  2020-07       Impact factor: 2.345

2.  Reduction in acute filariasis morbidity during a mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea.

Authors:  Daniel J Tisch; Neal D E Alexander; Benson Kiniboro; Henry Dagoro; Peter M Siba; Moses J Bockarie; Michael P Alpers; James W Kazura
Journal:  PLoS Negl Trop Dis       Date:  2011-07-12

3.  Morbidity management in the Global Programme to Eliminate Lymphatic Filariasis: a review of the scientific literature.

Authors:  David G Addiss; Molly A Brady
Journal:  Filaria J       Date:  2007-02-15

4.  The global programme to eliminate lymphatic filariasis: health impact after 8 years.

Authors:  Eric A Ottesen; Pamela J Hooper; Mark Bradley; Gautam Biswas
Journal:  PLoS Negl Trop Dis       Date:  2008-10-08

5.  Economic Costs and Benefits of a Community-Based Lymphedema Management Program for Lymphatic Filariasis in Odisha State, India.

Authors:  Eileen Stillwaggon; Larry Sawers; Jonathan Rout; David Addiss; LeAnne Fox
Journal:  Am J Trop Med Hyg       Date:  2016-08-29       Impact factor: 2.345

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.